Intravesical Bacillus Calmette‐Guérin versus mitomycin C for Ta and T1 bladder cancer

Reason for withdrawal from publication This review is being updated and replaced following the publication of a new protocol (Schmidt S, Kunath F, Coles B, Draeger DL, Krabbe L‐M, Dersch R, Jensen K, Dahm P, Meerpohl JJ. Intravesical bacillus Calmette‐Guérin versus mitomycin C for Ta and T1 bladder...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cochrane library 2015-11, Vol.2015 (11)
Hauptverfasser:	Shelley, Mike, Court, J B, Kynaston, Howard G, Wilt, Timothy J, Coles, Bernadette, Mason, Malcolm
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Intravesical Antibiotics, Antineoplastic Bacillus Calmette Guerin (BCG) BCG Vaccine Bladder Bladder cancer Bladder Cancer (Malignancy, Neoplasia): [Superficial, muscle‐invasive, metastatic Cancer Carcinoma in Situ Carcinoma, Transitional Cell Medicine General & Introductory Medical Sciences Mitomycin Randomized Controlled Trials as Topic Treatment of Superficial Bladder Cancer Urinary Bladder Neoplasms Urology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Reason for withdrawal from publication This review is being updated and replaced following the publication of a new protocol (Schmidt S, Kunath F, Coles B, Draeger DL, Krabbe L‐M, Dersch R, Jensen K, Dahm P, Meerpohl JJ. Intravesical bacillus Calmette‐Guérin versus mitomycin C for Ta and T1 bladder cancer [Protocol]. Cochrane Database of Systematic Reviews 2015, Issue 11. Art. No.: CD011935 DOI: 10.1002/14651858.CD011935). It will remain withdrawn when the new review is published.
ISSN:	1465-1858 1465-1858
DOI:	10.1002/14651858.CD003231.pub2